The impact of intensive antileukaemic treatment strategies on prognosis of myelodysplastic syndrome patients aged less than 61 years according to International Prognostic Scoring System risk groups

@article{Oosterveld2003TheIO,
  title={The impact of intensive antileukaemic treatment strategies on prognosis of myelodysplastic syndrome patients aged less than 61 years according to International Prognostic Scoring System risk groups},
  author={M. Oosterveld and S. Wittebol and W. Lemmens and B. Kiemeney and A. Çatik and P. Muus and A. Schattenberg and T. D. de Witte},
  journal={British Journal of Haematology},
  year={2003},
  volume={123}
}
  • M. Oosterveld, S. Wittebol, +5 authors T. D. de Witte
  • Published 2003
  • Medicine
  • British Journal of Haematology
  • Summary. The present study applied the International Prognostic Scoring System (IPSS) to 306 consecutive myelodysplastic syndrome (MDS) patients diagnosed between August 1977 and September 2000 at the University Medical Centre Nijmegen. The aim was to investigate whether the IPSS could be used as a prognostic tool in MDS patients aged less than 61 years who were treated with acute myeloid leukaemia (AML)‐like chemotherapy with or without transplantation, and whether the scoring system… CONTINUE READING

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 28 REFERENCES
    Proposals for the classification of the myelodysplastic syndromes
    • 3,694
    • PDF
    Myelodysplastic syndromes: a scoring system with prognostic significance
    • 505